Clinical Trials
2 trialsNCT06687070 2025-02-26
APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST
Ascentage Pharma Group Inc.
Phase 1 Recruiting
NCT02644278 2019-09-09
First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With Chemotherapy
EMD Serono
Phase 1 Completed